GlassScriptPhysician profile
Christine Kerrigan
NPI 1467013854
$628.63
in general payments reported to CMS, 2019-2025
8 companies · $241 in 2025
The $241 reported for 2025 was more than what 80% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.99 · 2021: $96.98 · 2022: $74.02 · 2023: $56.25 · 2024: $149 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $445.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $414.41 | 2021-2025 | Invisalign |
| Orapharma, A Division of Bausch Health US, LLC | $58.49 | 2021-2023 | Ossix Plus |
| Philips North America LLC | $39.22 | 2019-2025 | Oral Health Care Undivided |
| Envista Holdings Corporation | $33.10 | 2024 | Maxcem Elite |
| Sonendo INC | $32.50 | 2022 | |
| Kerr Corporation | $27.70 | 2021 | |
| Gc America INC. | $13.10 | 2022 | |
| Voco America INC. | $10.11 | 2023 | Admira Fusion, Voco Profluorid Varnish, Grandio So Heavy Flow |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Kerrigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.